751 results on '"Levy, Wayne C."'
Search Results
102. Time trends in sudden cardiac death risk in heart failure patients with cardiac resynchronization therapy: a systematic review
103. Years-needed-to-treat to add 1 year of life: a new metric to estimate treatment effects in randomized trials
104. The Effects of Atorvastatin (10 mg) on Systemic Inflammation in Heart Failure
105. Confirmation of Chagas' cardiomyopathy following heart transplantation
106. Risk Models for Prediction of Implantable Cardioverter-Defibrillator Benefit:Insights From the DANISH Trial
107. Drifting in a shrinking future: living with advanced heart failure
108. trans Fatty acids and systemic inflammation in heart failure
109. Depression and health status in patients with advanced heart failure: a prospective study in tertiary care
110. Sudden cardiac death after acute decompensation in heart failure patients: implications of discharge haemoglobin levels.
111. Prognostic usefulness of planar 123I-MIBG scintigraphic images of myocardial sympathetic innervation in congestive heart failure: Follow-Up data from ADMIRE-HF.
112. Oxygen Cost of Exercise Is Increased in Heart Failure After Accounting for Recovery Costs*
113. Norepinephrine alters exercise oxygen consumption in heart failure patients
114. Comparison of Neurologic Event Rates Among HeartMate II, HeartMate 3, and HVAD
115. Left Ventricular Assist Device Inflow Cannula Insertion Depth Influences Thrombosis Risk
116. Ejection Fraction Relative to Improvements in Mitral Regurgitation and Left Ventricular Remodeling after Implantation of Carillon Device
117. Modeling Outcomes for Ventricular Tachycardia Ablation in Nonischemic Dilated Cardiomyopathy
118. Accuracy of Doppler blood pressure measurement in continuous‐flow left ventricular assist device patients
119. Validity of the Seattle Heart Failure Model after heart failure hospitalization
120. Utility of the Seattle Heart Failure Model for palliative care referral in advanced ambulatory heart failure
121. Echocardiographic Insights into the Hemodynamics of Systolic Heart Failure: Can This Guide Titration of Medical Therapy?
122. Comparison of cardiopulmonary-based risk models with a clinical heart failure risk model
123. Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators
124. Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction
125. Agreement between risk and priority for heart transplant: Effects of the geographic allocation rule and status assignment
126. Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators
127. Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non–Inotrope-Dependent Advanced Heart Failure Patients
128. Should Nonischemic CRT Candidates Receive CRT-P or CRT-D? ∗
129. Use of Risk Models to Predict Death in the Next Year Among Individual Ambulatory Patients With Heart Failure
130. PERFORMANCE OF THE SEATTLE HEART FAILURE MODEL IN PATIENTS DISCHARGED AFTER ACUTE HEART FAILURE HOSPITALIZATION
131. Abstract 13962: Goals of Care Intervention in Advanced Heart Failure
132. Predicting Survival in Patients With Heart Failure With an Implantable Cardioverter Defibrillator: The Heart Failure Meta-Score.
133. Should Heart Failure Patients Move to Catalonia?
134. Effect of regional competition on heart transplant waiting list outcomes
135. From statistical significance to clinical relevance: A simple algorithm to integrate brain natriuretic peptide and the Seattle Heart Failure Model for risk stratification in heart failure
136. Assessment of the Effects of Age, Gender, and Exercise Training on the Cardiac Sympathetic Nervous System Using Positron Emission Tomography Imaging
137. Pretransplant coagulopathy and in-hospital outcomes among heart transplant recipients: a propensity-matched nationwide inpatient sample study.
138. Abstract 19802: Implantable Hemodynamic Monitoring Reduces Heart Failure Hospitalizations Due to Congestion Regardless of Perfusion Status
139. Reply to the Editor— A novel method to predict the proportional risk from sudden cardiac death in heart failure: Derivation of the Seattle Proportional Risk Model
140. Adverse Effects of Delayed Transplant Listing Among Patients With Implantable Left Ventricular Assist Devices.
141. An Appraisal of Biomarker-Based Risk-Scoring Models in Chronic Heart Failure: Which One Is Best?
142. Risk Models for Prediction of Implantable Cardioverter-Defibrillator Benefit
143. MP-453090-7 IDENTIFYING PATIENTS WITH LVEF≤55% WHO MAY BENEFIT FROM A PRIMARY PREVENTION ICD USING SEATTLE PROPORTIONAL RISK MODEL FOR MILDLY REDUCED EF (SPRM-MR) IN 14,752 PATIENTS.
144. Improved outcome with repeated intracoronary injection of bone marrow-derived cells within a registry: rationale for the randomized outcome trial REPEAT
145. A novel method to predict the proportional risk of sudden cardiac death in heart failure: Derivation of the Seattle Proportional Risk Model
146. Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with heart failure
147. Digoxin
148. Opportunity to Increase Life Span in Narrow QRS Cardiac Resynchronization Therapy Recipients by Deactivating Ventricular Pacing
149. BENEFITS OF ICD THERAPY: CONNECTING TREATMENT DECISIONS TO INDIVIDUALIZED SCD RISK ESTIMATES WITHIN MADIT-II USING THE SEATTLE PROPORTIONAL RISK MODEL
150. Pretransplant Coagulopathy and In-hospital Outcomes Among Heart Transplant Recipients: A Propensity-Matched Nationwide Inpatient Sample Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.